Soleus Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.3M | Buy |
209,794
+54,400
| +35% | +$15.6M | 3.99% | 4 |
|
|
2025
Q1 | $47.9M | Buy |
155,394
+46,000
| +42% | +$14.2M | 3.45% | 7 |
|
|
2024
Q4 | $38.6M | Buy |
109,394
+7,500
| +7% | +$2.65M | 2.43% | 12 |
|
|
2024
Q3 | $36.5M | Sell |
101,894
-39,605
| -28% | -$14.2M | 2.83% | 8 |
|
|
2024
Q2 | $45.1M | Sell |
141,499
-118,250
| -46% | -$37.7M | 3.98% | 3 |
|
|
2024
Q1 | $59.7M | Buy |
259,749
+10,300
| +4% | +$2.37M | 4.43% | 1 |
|
|
2023
Q4 | $54.9M | Sell |
249,449
-37,716
| -13% | -$8.29M | 6.09% | 2 |
|
|
2023
Q3 | $64.9M | Buy |
287,165
+44,430
| +18% | +$10M | 5.98% | 1 |
|
|
2023
Q2 | $53.6M | Buy |
242,735
+106,500
| +78% | +$23.5M | 5.96% | 1 |
|
|
2023
Q1 | $30.5M | Buy |
136,235
+7,967
| +6% | +$1.78M | 3.16% | 6 |
|
|
2022
Q4 | $35.7M | Sell |
128,268
-106,591
| -45% | -$29.6M | 5.12% | 3 |
|
|
2022
Q3 | $49.2M | Sell |
234,859
-60,682
| -21% | -$12.7M | 6.68% | 1 |
|
|
2022
Q2 | $69.6M | Sell |
295,541
-10,309
| -3% | -$2.43M | 10.86% | 1 |
|
|
2022
Q1 | $54.9M | Buy |
305,850
+141,550
| +86% | +$25.4M | 7.08% | 1 |
|
|
2021
Q4 | $35.5M | Buy |
164,300
+62,500
| +61% | +$13.5M | 3.55% | 4 |
|
|
2021
Q3 | $18.8M | Buy |
+101,800
| New | +$18.8M | 2.93% | 11 |
|